Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Unternehmen

Zurich delivers USD 8.9bn operating profit, raises dividend to CHF 30, strong progress toward 2027 targets » Report
Zug Estates Holding AG - Strong annual result for the Zug Estates Group » Report
Zug Estates Holding AG - Starkes Jahresergebnis der Zug Estates Gruppe » Report
NOVAVEST Real Estate AG erzielt starke Ergebnisse im Geschäftsjahr 2025 » Report
TKB präsentiert ein Spitzenergebnis » Report
Avolta expands in Italy with new entry and F&B growth at Verona and Florence airports » Report
Amrize Closes Acquisition of PB Materials; Aggregates Leader in High-Growth West Texas » Report
Logitech - 4 (Statement of Changes in Beneficial Ownership) SEC Filing » Report
Nestlé proposes Ma. Fatima D. Francisco and Thomas Jordan for election to its Board of Directors; updates its governance practices » Report
Glencore finalises agreement with Gécamines for land access at KCC » Report
Glencore: Preliminary Results 2025 » Report
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU) » Report
Sunrise raggiunge i propri obiettivi finanziari, conferma una crescita dei dividendi del 2,7% nel 2025 e prevede una politica progressiva anche per il 2026 » Report
Sunrise meets its financial targets, confirms 2.7% dividend growth for the 2025 financial year and expects progressive dividend‑per‑share policy for 2026 » Report
Sunrise atteint ses objectifs financiers, confirme une croissance du dividende de 2,7% pour l’exercice 2025 et prévoit une politique de dividende progressive pour 2026 » Report
Sunrise erreicht Finanzziele, bestätigt 2,7% Dividendenwachstum fürs Jahr 2025 und erwartet progressive Dividendenpolitik fürs Jahr 2026 » Report
EFG: Strong NNA¹ of CHF 11.3 billion and record net profit of CHF 325.2 million in 2025; proposing record dividend of CHF 0.65 per share » Report
CPH Geschäftsjahr 2025: Strategische Weichenstellungen in forderndem Umfeld » Report
Sandoz Group AG - Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications » Report
Straumann Holding AG - Straumann Group delivers strong 2025 performance with continued market share gains, innovation and strategic progress » Report